W. L. Alan Fung, M.D., Sc.D.
Wai Lun Alan Fung, M.D., Sc.D., Assistant Professor, University of Toronto Faculty of Medicine; Chair of Research Ethics Board and Medical Director of Research, Department of Psychiatry, North York General Hospital, 4001 Leslie Street, Toronto, ON M2K 1E1, Canada
Wai Lun Alan Fung is a medical specialist in psychiatry who is also board certified in the subspecialties of Behavioral Neurology & Neuropsychiatry (United Council for Neurologic Subspecialties, United States) and Sleep Medicine (American Board of Psychiatry and Neurology). He serves as Medical Director of Research of the Department of Psychiatry, as well as Chair of the Research Ethics Board, at North York General Hospital—an affiliated teaching hospital of the University of Toronto Faculty of Medicine in Toronto, Ontario, Canada. He is also Assistant Professor of Psychiatry at the University of Toronto as well as Affiliate Scientist of the Toronto General Research Institute. As a neuropsychiatrist focusing on genetic disorders, he has particular clinical and academic interests in 22q11.2 deletion syndrome (22q11.2DS) and Huntington disease in adults and in adolescents making the transition to adulthood. His interests in intellectual and developmental disabilities were first ignited through a medical school research project as part of Ivan Brown's pioneering Family Quality of Life in Intellectual Disabilities study. Dr. Fung has subsequently continued his professional involvement with intellectual and developmental disabilities through his work in 22q11.2DS. He was the lead co-first-author of the first set of guidelines for managing adult patients with 22q11.2DS, endorsed by the 22q11.2 Society (the international professional organization dedicated to the study of chromosome 22q11.2 and related disorders). He has also served as Founding Knowledge Officer of The 22q11.2 Society. During 2012–2015, he served as Founding Co-Director of the Dalglish Family 22q Clinic at Toronto General Hospital in Canada—the first comprehensive, multidisciplinary clinic of its kind worldwide fully dedicated to the care of adults with 22q11.2DS and their families. He is a member of the International Consortium on Brain and Behavior in 22q11.2DS as well as an investigator member of the Huntington Study Group. He has also served in leadership roles in such professional organizations as the American Psychiatric Association and the American Neuropsychiatric Association. His other professional interests include neuropsychiatric genetics and pharmacogenetics; the cultural and spiritual dimensions of mental health care; medical quality improvement through knowledge mobilization, utilization of information technology, intra- and interprofessional collaboration, and education; and patient- and family-centered collaborative care. He has published in leading journals such as Journal of the American Medical Association, JAMA Psychiatry, Lancet Psychiatry, American Journal of Psychiatry, British Journal of Psychiatry, World Psychiatry, Neurology, Genetics in Medicine, and Social Science and Medicine. Dr. Fung completed his undergraduate and medical degrees, as well as his residency training in psychiatry, at the University of Toronto. He also completed a master's degree in epidemiology at the University of Cambridge, United Kingdom, and a research doctorate and research fellowship in neuropsychiatric genetic epidemiology at Harvard University. He is a Fellow of both the Royal College of Physicians of Canada and the American Psychiatric Association.